Skip to content

Availability of free door-to-door transport to increase the attendance of breast screening appointments in Yorkshire

Evaluating the effectiveness and acceptability of free door-to-door transport to increase the uptake of breast screening appointments in Yorkshire: a cluster randomised GP pilot trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN17087898
Enrollment
8000
Registered
2025-02-19
Start date
2024-08-13
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer Cancer

Interventions

The intervention is the offer of free door-to-door transport to a routine breast screening appointment for all eligible women registered at GP practices randomised to the intervention arm of the trial

Sponsors

University of Hull
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
50 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. GPs located in East Riding of Yorkshire or Kingston Upon Hull 2. Whose women meet the age criteria for the national breast screening programme (between 50 and 70 years old) and are due to be invited to attend a routine screening appointment during the intervention window

Exclusion criteria

Exclusion criteria: 1. GP practices located outside of the set geographical area 2. Women with non-routine screening appointments

Design outcomes

Primary

MeasureTime frame
As a feasibility trial, the primary aim is to assess the feasibility of conducting the future definitive RCT. The primary feasibility outcomes are summarised along with criteria that will be used as a guide for progression to a future definitive Phase III trial and described here: 1. Number of GP practices that agreed to participate and were randomised ahead of the scheduled breast screening invitation window 2. Percentage of women invited from GP practices located in the 10% most deprived areas 3. Percentage of intervention invites sent out by the BSS to all women during the scheduled breast screening invitation window 4. Percentage of women who requested transport who were transported to and from their appointment by the service 5. Acceptability of the intervention to the women and the service providers 6. Completion and transfer of the screening and transport service data when required for analysis All measured at the end of the study

Secondary

MeasureTime frame
The secondary outcomes are summarised below and are the intended outcomes for the definitive trial, and the data that will help inform sample size calculations for the Phase III trial. 1. Screening uptake rates: percentage attendance at screening appointments, exploring if there is a signal of efficacy (increase in screening rates in the transport intervention arm compared to usual care) 2. Transport intervention uptake rates 3. Cost-effectiveness: estimates of the cost-effectiveness of the transport intervention All measured at the end of the study

Countries

England, United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 14, 2026